S&P 500
(-1.46%) 5 123.41 points
Dow Jones
(-1.24%) 37 983 points
Nasdaq
(-1.62%) 16 175 points
Oil
(0.51%) $85.45
Gas
(0.51%) $1.773
Gold
(-0.53%) $2 360.20
Silver
(-0.99%) $27.97
Platinum
(0.18%) $989.80
USD/EUR
(0.79%) $0.939
USD/NOK
(0.59%) $10.89
USD/GBP
(0.83%) $0.803
USD/RUB
(0.01%) $93.28

Realtime updates for Sanofi American [SNY]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturersā€”General
BUY
74.47%
return 5.76%
SELL
29.79%
return 6.47%
Last Updated12 Apr 2024 @ 16:00

-1.44% $ 45.93

BUY 2289 min ago

@ $46.59

Issued: 11 Apr 2024 @ 15:49


Return: -1.41%


Previous signal: Apr 11 - 13:25


Previous signal: Sell


Return: -0.32 %

Live Chart Being Loaded With Signals

Commentary (12 Apr 2024 @ 16:00):
Profile picture for Sanofi American Depositary Shares (Each repstg one-half of one)

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally...

Stats
Today's Volume 1.35M
Average Volume 1.87M
Market Cap 106.90B
EPS $0 ( 2024-02-01 )
Next earnings date ( $0.980 ) 2024-04-25
Last Dividend $1.903 ( 2023-05-30 )
Next Dividend $0 ( N/A )
P/E 19.71
ATR14 $0.327 (0.71%)

Volume Correlation

Long: -0.21 (neutral)
Short: -0.48 (neutral)
Signal:(51) Neutral

Sanofi American Correlation

10 Most Positive Correlations
PPH0.936
PWOD0.93
ACAHU0.925
WLFC0.914
NWFL0.914
EVOP0.913
ROST0.91
SGHT0.909
HZNP0.907
MGI0.907
10 Most Negative Correlations
LNSR-0.936
MEDS-0.922
VS-0.919
LHDX-0.915
STRC-0.912
TIL-0.911
QLGN-0.91
ULBI-0.91
PLMR-0.909
SG-0.909

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sanofi American Correlation - Currency/Commodity

The country flag 0.07
( neutral )
The country flag 0.19
( neutral )
The country flag 0.00
( neutral )
The country flag -0.14
( neutral )
The country flag 0.00
( neutral )
The country flag -0.17
( neutral )

Sanofi American Financials

Annual 2023
Revenue: $43.07B
Gross Profit: $26.50B (61.52 %)
EPS: $4.31
Q4 2023
Revenue: $22.88B
Gross Profit: $14.68B (64.16 %)
EPS: $1.570
Q3 2023
Revenue: $12.70B
Gross Profit: $8.86B (69.75 %)
EPS: $2.01
Q2 2023
Revenue: $10.68B
Gross Profit: $7.41B (69.41 %)
EPS: $2.74

Financial Reports:

No articles found.

Sanofi American Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$3.28
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Sanofi American Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.30 - Increase likely (46.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.462 2003-05-28
Last Dividend $1.903 2023-05-30
Next Dividend $0 N/A
Payout Date 2023-06-23
Next Payout Date N/A
# dividends 24 --
Total Paid Out $33.25 --
Avg. Dividend % Per Year 3.34% --
Score 4.99 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.30
Div. Directional Score 9.72 --
Next Divdend (Est)
(2025-02-10)
$1.985 Estimate 3.15 %
Dividend Stability
0.25 Very Poor
Dividend Score
4.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2003 $0.462 1.49%
2004 $0.610 1.60%
2005 $0.799 2.01%
2006 $0.912 2.00%
2007 $1.145 2.48%
2008 $1.510 3.31%
2009 $1.419 4.34%
2010 $1.627 3.99%
2011 $1.822 5.55%
2012 $1.756 4.72%
2013 $1.862 3.89%
2014 $1.910 3.69%
2015 $1.618 3.55%
2016 $1.630 3.86%
2017 $1.577 3.84%
2018 $1.861 4.30%
2019 $1.739 4.06%
2020 $1.753 3.46%
2021 $1.906 3.91%
2022 $2.04 4.02%
2023 $3.28 6.69%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1391.5007.2310.00[0 - 0.5]
returnOnAssetsTTM0.06271.2007.919.49[0 - 0.3]
returnOnEquityTTM0.1081.5009.9210.00[0.1 - 1]
payoutRatioTTM0.579-1.0004.21-4.21[0 - 1]
currentRatioTTM1.2670.8008.666.93[1 - 3]
quickRatioTTM0.8270.8009.847.87[0.8 - 2.5]
cashRatioTTM0.3601.5009.1110.00[0.2 - 2]
debtRatioTTM0.132-1.5007.80-10.00[0 - 0.6]
interestCoverageTTM9.291.0007.677.67[3 - 30]
operatingCashFlowPerShareTTM8.202.007.2710.00[0 - 30]
freeCashFlowPerShareTTM5.602.007.2010.00[0 - 20]
debtEquityRatioTTM0.225-1.5009.10-10.00[0 - 2.5]
grossProfitMarginTTM0.6781.0002.032.03[0.2 - 0.8]
operatingProfitMarginTTM0.2601.0006.806.80[0.1 - 0.6]
cashFlowToDebtRatioTTM0.6151.0007.697.69[0.2 - 2]
assetTurnoverTTM0.4520.800-0.322-0.258[0.5 - 2]
Total Score12.14

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.911.0008.700[1 - 100]
returnOnEquityTTM0.1082.509.9510.00[0.1 - 1.5]
freeCashFlowPerShareTTM5.602.008.1310.00[0 - 30]
dividendYielPercentageTTM4.041.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.202.007.2710.00[0 - 30]
payoutRatioTTM0.5791.5004.21-4.21[0 - 1]
pegRatioTTM0.6351.5009.100[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1801.0008.010[0.1 - 0.5]
Total Score7.30

Sanofi American

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators